PHPSX Holdings — Pharmaceuticals
All 60 reported holdings of Pharmaceuticals (PHPSX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Organon & Company | 2.73% | $91.92K |
| Corcept Therapeutics, Inc. | 1.82% | $61.22K |
| Enliven Therapeutics, Inc. | 1.77% | $59.62K |
| Axsome Therapeutics, Inc. | 1.71% | $57.75K |
| Omeros Corp. | 1.61% | $54.34K |
| Perrigo Company PLC | 1.59% | $53.59K |
| Definium Therapeutics, Inc. | 1.55% | $52.14K |
| Nektar Therapeutics | 1.53% | $51.45K |
| Trevi Therapeutics, Inc. | 1.52% | $51.16K |
| Terns Pharmaceuticals, Inc. | 1.49% | $50.23K |
| Indivior Pharmaceuticals, Inc. | 1.48% | $49.73K |
| Pacira Biosciences, Inc. | 1.47% | $49.58K |
| Harrow, Inc. | 1.45% | $48.72K |
| Jazz Pharmaceuticals PLC | 1.44% | $48.52K |
| Harmony Biosciences Holdings, Inc. | 1.43% | $48.20K |
| Royalty Pharma PLC | 1.41% | $47.64K |
| Amylyx Pharmaceuticals, Inc. | 1.41% | $47.58K |
| Viatris, Inc. | 1.41% | $47.48K |
| Crinetics Pharmaceuticals, Inc. | 1.38% | $46.57K |
| Ani Pharmaceuticals, Inc. | 1.37% | $46.24K |
| Ligand Pharmaceuticals, Inc. | 1.37% | $46.12K |
| Mbx Biosciences, Inc. | 1.35% | $45.63K |
| Innoviva, Inc. | 1.35% | $45.52K |
| Liquidia Corp. | 1.34% | $45.13K |
| Amneal Pharmaceuticals, Inc. | 1.33% | $44.95K |
| Xeris Biopharma Holdings, Inc. | 1.33% | $44.94K |
| Bristol-Myers Squibb Company | 1.33% | $44.84K |
| Edgewise Therapeutics, Inc. | 1.32% | $44.37K |
| Ocular Therapeutix, Inc. | 1.30% | $43.79K |
| Pfizer, Inc. | 1.29% | $43.41K |
| Nuvation Bio, Inc. | 1.28% | $43.04K |
| Zoetis, Inc. | 1.27% | $42.65K |
| Elanco Animal Health, Inc. | 1.26% | $42.35K |
| Johnson & Johnson | 1.25% | $42.06K |
| Collegium Pharmaceutical, Inc. | 1.25% | $42.03K |
| Merck & Company, Inc. | 1.24% | $41.71K |
| Alumis, Inc. | 1.24% | $41.63K |
| Eli Lilly & Company | 1.22% | $41.12K |
| Tarsus Pharmaceuticals, Inc. | 1.20% | $40.39K |
| Supernus Pharmaceuticals, Inc. | 1.19% | $40.03K |
| Phibro Animal Health Corp. | 1.18% | $39.83K |
| Eyepoint, Inc. | 1.17% | $39.28K |
| Prestige Consumer Healthcare, Inc. | 1.14% | $38.58K |
| Amphastar Pharmaceuticals, Inc. | 1.12% | $37.60K |
| Theravance Biopharma, Inc. | 1.00% | $33.85K |
| Phathom Pharmaceuticals, Inc. | 1.00% | $33.60K |
| Rapport Therapeutics, Inc. | 0.99% | $33.53K |
| Esperion Therapeutics, Inc. | 0.98% | $33.01K |
| Cormedix, Inc. | 0.94% | $31.64K |
| Agpxx | 0.91% | $30.68K |
| Arvinas, Inc. | 0.80% | $26.96K |
| Bioage Labs, Inc. | 0.79% | $26.74K |
| Zevra Therapeutics, Inc. | 0.74% | $24.85K |
| Maze Therapeutics, Inc. | 0.69% | $23.39K |
| Septerna, Inc. | 0.68% | $22.98K |
| Wave Life Sciences Ltd. | 0.66% | $22.26K |
| Lb Pharmaceuticals, Inc. | 0.63% | $21.28K |
| Fulcrum Therapeutics, Inc. | 0.58% | $19.71K |
| Aquestive Therapeutics, Inc. | 0.55% | $18.51K |
| Alto Neuroscience, Inc. | 0.42% | $14.14K |
PHPSX overview: performance, fees, allocation and SEC filings